Peptide neurotransmitters and myocardial ischaemia

Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.

Thrombosis research·2010

A European view on the North American fifth consensus on antithrombotic therapy.

Chest·2000

Are symptomatic endpoints acceptable in venous thromboprophylactic studies?

Haemostasis·1999

Aspirin: benefit and risk in thromboprophylaxis.

QJM : monthly journal of the Association of Physicians·1999

Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events.

Thrombosis research·1998

The influence of the milieu on the rate of neutralisation of herpes simplex virus 1.

Archives of virology·1998

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Porcine coronavirus promotes NLRP3 inflammasome activation during virus-induced neuroinflammation.

mBio·2026

Patterns of Neurological Recovery after Posterior Decompression Without Fusion for Degenerative Cervical Myelopathy According to the Timing of Minimum Clinically Important Difference Achievement.

Global spine journal·2026

Management Patterns and Outcomes of Vestibular Schwannoma in Older Adults: Assessment of the SEER Database.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·2026

Paeonol as a Multi-Target Therapy for Neurological Disorders: Mechanistic Insights Into Neuroprotection.

Immunity, inflammation and disease·2026

Combined Vitamin D and Resveratrol Treatment Attenuates Motor Deficits and Neurodegeneration in a 6-OHDA Mouse Model of Parkinson's Disease in Male Mice: A Focus on Sirt1 and Lingo-1 Pathways in the Ventral Tegmental Area.

Brain and behavior·2026

Unraveling the Inflammatory Enigma: Is Neuroinflammation a Culprit or Consequence in Pharmacoresistant Epilepsy?

Brain and behavior·2026

Related Experiment Videos

Peptide neurotransmitters and myocardial ischaemia

Related Concept Videos

Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.

A European view on the North American fifth consensus on antithrombotic therapy.

Are symptomatic endpoints acceptable in venous thromboprophylactic studies?

Aspirin: benefit and risk in thromboprophylaxis.

Anticardiolipin antibodies in clinical conditions associated with a risk of thrombotic events.

The influence of the milieu on the rate of neutralisation of herpes simplex virus 1.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Porcine coronavirus promotes NLRP3 inflammasome activation during virus-induced neuroinflammation.

Patterns of Neurological Recovery after Posterior Decompression Without Fusion for Degenerative Cervical Myelopathy According to the Timing of Minimum Clinically Important Difference Achievement.

Management Patterns and Outcomes of Vestibular Schwannoma in Older Adults: Assessment of the SEER Database.

Paeonol as a Multi-Target Therapy for Neurological Disorders: Mechanistic Insights Into Neuroprotection.

Combined Vitamin D and Resveratrol Treatment Attenuates Motor Deficits and Neurodegeneration in a 6-OHDA Mouse Model of Parkinson's Disease in Male Mice: A Focus on Sirt1 and Lingo-1 Pathways in the Ventral Tegmental Area.

Unraveling the Inflammatory Enigma: Is Neuroinflammation a Culprit or Consequence in Pharmacoresistant Epilepsy?

Related Experiment Videos

Peptide neurotransmitters and myocardial ischaemia

Related Concept Videos

Related Articles